270 Views | 190 Downloads
Corresponding Author: David J. Murphy, MD, PhD, Emory University School of Medicine, 49 Jesse Hill Jr. Drive, Atlanta, GA 30303, david.j.murphy@emory.edu, Fax: 404-616-8455
Dr. Roback disclosed other relationships/activities (unrelated to manuscript): 1) Member, Clinical Transfusion Medicine Committee, American Association of Blood Banks (2014 - present) 2) Chair and Member, NIH/NHLBI Review Group ZRG1 VH-F (55)R, Selected Topics in Transfusion Medicine (2015) 3) Standing Member, NHLBI Program Projects Review Committee (2015 – 2019) 4) Consultant, UnitedPharma, Duluth, GA (MacoPharma US; CLIA 11D1052845) (2006 – 2016) 5) Consultant, Transfusion & Transplantation Technologies LLC (3Ti), Atlanta, GA (CLIA 11D1054838) (2008 – 2016) 6) Consultant, Castle Medical, Inc., Smyrna, GA (CLIA 11D2017949) (2010 – present) 7) Consultant, CSL Plasma, Inc., Decatur, GA (CLIA 11D2064762) (2013 – present) 8) Consultant, BioMet, Warsaw Indiana (2014 – present) 9) Editorial Board: Transfusion (Journal of the American Association of Blood Banks; AABB); 2004 – present).
See publication full list of acknowledgement.
Conflicts of interest: None
Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454 and TL1TR000456.
Dr. Murphy received support for article research from the National Institutes of Health (NIH). His institution received funding (Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454 and TL1TR000456).
Dr. Seitz received support for article research from the National Institutes of Health (NIH) and disclosed other (He was supported by a grant from the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR000454).
Dr. Sevransky received funding from the Food and Drug Administration and received support for article research from the FDA. His institution received funding from the Society for Critical Care Medicine
Dr. Martin received support for article research from the NIH and received funding from CR Bard, Cumberland Pharmaceuticals, and Grifols. His institution received funding from the NIH & FDA, Baxter Healthcare.
© 2017 Society of Critical Care Medicine and Wolters Kluwer Health, Inc.